Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Aug 14, 2008

TGen to Assess febit’s DNA Capture Method in Next-Generation Sequencing Efforts

  • Translational Genomics Research Institute (TGen) will febit's HybSelect™ in next-generation sequencing equipment. The partnership thus provides TGen scientists premarket access to this technology, which is a method for capturing DNA.

    “We will obtain important data from TGen that will help us as we prepare for the official introduction of HybSelect in early 2009,” says Cord F. Staehler, president of febit.

    HybSelect enables selective DNA capture and elution, an efficient method to preselect sequences for next-generation sequencers, the companies report. It is based on febit's Geniom Technology and uses arrays within microfluidic biochips for the selection process of targeted DNA. Geniom biochips are programmable and can contain any desired set of capture probes.



Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »